BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 16088092)

  • 1. Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy.
    Colicchio P; Tarantino G; del Genio F; Sorrentino P; Saldalamacchia G; Finelli C; Conca P; Contaldo F; Pasanisi F
    Ann Nutr Metab; 2005; 49(5):289-95. PubMed ID: 16088092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic steatosis in obese Chinese children.
    Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
    Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors related to non-alcoholic fatty liver disease in obese children.
    Eminoğlu TF; Camurdan OM; Oktar SO; Bideci A; Dalgiç B
    Turk J Gastroenterol; 2008 Jun; 19(2):85-91. PubMed ID: 19110662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminotransferase activity in morbid and uncomplicated obesity: predictive role of fasting insulin.
    Iacobellis G; Moschetta A; Buzzetti R; Ribaudo MC; Baroni MG; Leonetti F
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):442-7. PubMed ID: 17134955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.
    Grattagliano I; Ubaldi E; Napoli L; Marulli CF; Nebiacolombo C; Cottone C; Portincasa P
    Ann Hepatol; 2013; 12(1):70-7. PubMed ID: 23293196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level.
    Huang SC; Yang YJ
    J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):145-50. PubMed ID: 22983378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty.
    Luyckx FH; Desaive C; Thiry A; Dewé W; Scheen AJ; Gielen JE; Lefèbvre PJ
    Int J Obes Relat Metab Disord; 1998 Mar; 22(3):222-6. PubMed ID: 9539189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin, body mass index and hepatic steatosis are independently associated with IGF-I status in obese non-diabetic women.
    Sirbu A; Gologan S; Arbanas T; Copaescu C; Martin S; Albu A; Barbu C; Pirvulescu I; Fica S
    Growth Horm IGF Res; 2013; 23(1-2):2-7. PubMed ID: 23111188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; de la Fuente B; Perez Castrillon JL
    Eur Rev Med Pharmacol Sci; 2009; 13(6):413-8. PubMed ID: 20085121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
    Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
    Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease.
    Esteghamati A; Noshad S; Khalilzadeh O; Khalili M; Zandieh A; Nakhjavani M
    Metab Syndr Relat Disord; 2011 Apr; 9(2):111-7. PubMed ID: 21091060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.
    Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M
    Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society.
    Soresi M; Noto D; Cefalù AB; Martini S; Vigna GB; Fonda M; Manzato E; Cattin L; Fellin R; Averna MR; Notarbartolo A;
    Acta Diabetol; 2013 Apr; 50(2):241-9. PubMed ID: 22684314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
    Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
    Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease.
    Fenkci S; Rota S; Sabir N; Akdag B
    Eur J Med Res; 2007 Feb; 12(2):68-73. PubMed ID: 17369120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
    Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of non-alcoholic fatty liver disease in obese children.
    Sartorio A; Del Col A; Agosti F; Mazzilli G; Bellentani S; Tiribelli C; Bedogni G
    Eur J Clin Nutr; 2007 Jul; 61(7):877-83. PubMed ID: 17151586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement.
    Koot BG; van der Baan-Slootweg OH; Tamminga-Smeulders CL; Rijcken TH; Korevaar JC; van Aalderen WM; Jansen PL; Benninga MA
    Arch Dis Child; 2011 Jul; 96(7):669-74. PubMed ID: 21518734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.